Computational investigation shows L-DOPA has the strongest binding interaction in therapeutic drug design for dopamine receptors, highlighting molecular dynamics and interactions.
The receptor–ligand interactions are crucial for understanding the mechanisms of biological regulation and these interactions give a theoretical basis for the design and discovery of new drug targets. Understanding the molecular interactions between D 2 dopamine receptor and dopamine‐related analogues is essential for designing effective therapeutics. In this study, we performed a comprehensive computational investigation of the binding interactions between D 2 R and a set of catecholamines (dopamine, adrenaline, and noradrenaline) along with L‐DOPA and epinine, structurally related analogues with pharmacological significance. Molecular docking was carried out to predict binding poses and affinities, followed by molecular dynamics (MD) simulations to assess the stability and conformational dynamics of the ligand‐receptor complexes. Binding free energy using the MM‐PBSA method, NCIPLOT, QTAIM and SAPT energy decomposition are carried out to provide quantitative insights into ligand binding strengths. The results indicated that L‐DOPA exhibits the most stable interaction with D 2 R, forming persistent hydrogen bonds and hydrophobic contacts within the receptor's orthosteric binding site.
No takes yet. Share an insight, caveat, or question.
Baro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: